Tristan Scott

908 total citations
24 papers, 668 citations indexed

About

Tristan Scott is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Tristan Scott has authored 24 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Tristan Scott's work include CRISPR and Genetic Engineering (7 papers), HIV Research and Treatment (5 papers) and Extracellular vesicles in disease (4 papers). Tristan Scott is often cited by papers focused on CRISPR and Genetic Engineering (7 papers), HIV Research and Treatment (5 papers) and Extracellular vesicles in disease (4 papers). Tristan Scott collaborates with scholars based in United States, Australia and South Africa. Tristan Scott's co-authors include Kevin V. Morris, Marc S. Weinberg, Roslyn M. Ray, Nicole Grepo, Patrick Arbuthnot, Abdullah Ely, John Burnett, Buhle Moyo, Sheena Saayman and Daniel C. Lazar and has published in prestigious journals such as Cell, Nature Communications and Scientific Reports.

In The Last Decade

Tristan Scott

23 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tristan Scott United States 13 484 169 104 104 101 24 668
Sheena Saayman United States 12 552 1.1× 71 0.4× 167 1.6× 97 0.9× 67 0.7× 17 680
Sergey Brezgin Russia 15 573 1.2× 77 0.5× 30 0.3× 70 0.7× 188 1.9× 44 759
Emmeline L. Blanchard United States 13 359 0.7× 352 2.1× 82 0.8× 92 0.9× 240 2.4× 20 806
Danilo Pellin United States 14 714 1.5× 163 1.0× 93 0.9× 339 3.3× 103 1.0× 29 1.0k
Jes Kuruvilla United States 8 281 0.6× 102 0.6× 97 0.9× 91 0.9× 42 0.4× 9 513
Jesse Thompson United States 12 275 0.6× 105 0.6× 113 1.1× 252 2.4× 104 1.0× 19 525
Pedro A. Lamothe United States 10 198 0.4× 135 0.8× 89 0.9× 43 0.4× 74 0.7× 18 584
Martin L. Koser United States 12 379 0.8× 123 0.7× 137 1.3× 77 0.7× 112 1.1× 17 608
Vera A. Tang Canada 13 252 0.5× 75 0.4× 68 0.7× 70 0.7× 109 1.1× 25 575
Ariko Miyake Japan 14 350 0.7× 155 0.9× 307 3.0× 91 0.9× 124 1.2× 42 837

Countries citing papers authored by Tristan Scott

Since Specialization
Citations

This map shows the geographic impact of Tristan Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tristan Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tristan Scott more than expected).

Fields of papers citing papers by Tristan Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tristan Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tristan Scott. The network helps show where Tristan Scott may publish in the future.

Co-authorship network of co-authors of Tristan Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Tristan Scott. A scholar is included among the top collaborators of Tristan Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tristan Scott. Tristan Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mooney, Rachael, Zhen Chen, Tristan Scott, et al.. (2025). Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease. Biomolecules. 15(7). 1000–1000. 2 indexed citations
2.
Tienhoven, René van, Denis O’Meally, Tristan Scott, et al.. (2025). Genetic protection from type 1 diabetes resulting from accelerated insulin mRNA decay. Cell. 188(9). 2407–2416.e9. 8 indexed citations
3.
Lee, C. Justin, Roslyn M. Ray, & Tristan Scott. (2024). Prospects and challenges of tissue-derived extracellular vesicles. Molecular Therapy. 32(9). 2950–2978. 15 indexed citations
4.
Scott, Tristan, et al.. (2023). Targeted zinc-finger repressors to the oncogenic HBZ gene inhibit adult T-cell leukemia (ATL) proliferation. NAR Cancer. 5(1). zcac046–zcac046. 2 indexed citations
5.
Urak, Ryan, Nicole Grepo, Lior Goldberg, et al.. (2023). Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells. Cancers. 15(10). 2848–2848. 2 indexed citations
6.
Scott, Tristan, et al.. (2022). Harnessing Rift Valley fever virus NSs gene for cancer gene therapy. Cancer Gene Therapy. 29(10). 1477–1486. 3 indexed citations
7.
Scott, Tristan, Aroon Supramaniam, Adi Idris, et al.. (2022). Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2. Molecular Therapy — Methods & Clinical Development. 24. 355–366. 33 indexed citations
8.
Ray, Roslyn M., et al.. (2021). Exosome-mediated stable epigenetic repression of HIV-1. Nature Communications. 12(1). 5541–5541. 61 indexed citations
9.
Idris, Adi, Aroon Supramaniam, Dhruba Acharya, et al.. (2021). A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19. Molecular Therapy. 29(7). 2219–2226. 125 indexed citations
10.
Scott, Tristan, et al.. (2020). Development of a Facile Approach for Generating Chemically Modified CRISPR/Cas9 RNA. Molecular Therapy — Nucleic Acids. 19. 1176–1185. 6 indexed citations
11.
Scott, Tristan, Denis O’Meally, Nicole Grepo, et al.. (2020). Broadly active zinc finger protein-guided transcriptional activation of HIV-1. Molecular Therapy — Methods & Clinical Development. 20. 18–29. 10 indexed citations
12.
Urak, Ryan, Roslyn M. Ray, Tristan Scott, et al.. (2020). Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV. Molecular Therapy — Methods & Clinical Development. 19. 285–294. 6 indexed citations
13.
Berg, Fiona T. van den, Makoah N. Aminake, Stuart A. Ali, et al.. (2019). AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region. Molecular Therapy — Methods & Clinical Development. 14. 100–112. 36 indexed citations
14.
Waters, Shafagh A., Tristan Scott, Sheena Saayman, et al.. (2019). Targeted Activation of Cystic Fibrosis Transmembrane Conductance Regulator. Molecular Therapy. 27(10). 1737–1748. 27 indexed citations
15.
Scott, Tristan, et al.. (2019). Improved Cas9 activity by specific modifications of the tracrRNA. Scientific Reports. 9(1). 16104–16104. 22 indexed citations
16.
Pinto, Daniel O., Tristan Scott, Catherine DeMarino, et al.. (2019). Effect of transcription inhibition and generation of suppressive viral non-coding RNAs. Retrovirology. 16(1). 13–13. 24 indexed citations
17.
Scott, Tristan, Buhle Moyo, Mohube Betty Maepa, et al.. (2017). ssAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells. Scientific Reports. 7(1). 7401–7401. 54 indexed citations
18.
Moyo, Buhle, Kristie Bloom, Tristan Scott, Abdullah Ely, & Patrick Arbuthnot. (2017). Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus. Virus Research. 244. 311–320. 55 indexed citations
19.
Saayman, Sheena, Daniel C. Lazar, Tristan Scott, et al.. (2015). 693. Potent and Targeted Activation of Latent HIV-1 Using Multiplexed Guide RNAs and the CRISPR/dCas9 Activator Complex. Molecular Therapy. 23. S276–S276. 6 indexed citations
20.
Saayman, Sheena, Daniel C. Lazar, Tristan Scott, et al.. (2015). Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Complex. Molecular Therapy. 24(3). 488–498. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sheena Saayman Breakdown of academic impact, for papers by Sergey Brezgin Breakdown of academic impact, for papers by Emmeline L. Blanchard Breakdown of academic impact, for papers by Danilo Pellin Breakdown of academic impact, for papers by Jes Kuruvilla Breakdown of academic impact, for papers by Jesse Thompson Breakdown of academic impact, for papers by Pedro A. Lamothe Breakdown of academic impact, for papers by Martin L. Koser Breakdown of academic impact, for papers by Vera A. Tang Breakdown of academic impact, for papers by Ariko Miyake
Rankless by CCL
2026